Anti-Prostate Cancer Drug Cabazitaxel CAS Number 183133-96-2

Payment Type: L/C,T/T
Incoterm: FOB
Min. Order: 1 Kilogram
Delivery Time: 15 Days

Basic Info

Model No.: 183133-96-2

Additional Info

Packaging: AS REQUIRED

Productivity: KGS


Transportation: Air

Place of Origin: CHINA


Certificate: ISO

Product Description

Cabazitaxel CAS number is183133-96-2, a chemically semisynthetic small molecule compound, was approved in the United States in June 2010 and is a second-line anti-prostate cancer drug. The anticancer mechanism and characteristics of Cabazitaxel similar to docetaxel, belongs to anti-microtubule drugs. Through the combination with tubulin, it promotes its assembly into microtubules, while preventing the assembled microtubules from disintegrating, stabilizing the microtubules, thereby inhibiting the mitosis of cells and the interphase cell function, and it is the first to use Commonly used advanced prostate cancer drug docetaxel ineffective or even worse when the preferred treatment of advanced, anti-prostate cancer drugs. Cabazitaxel offers a novel treatment for castration resistant prostate cancer patients, prompting hope for prostate cancer patients, although only modest gains have been achieved, confirming the effectiveness of immunotherapy for prostate cancer. Cabazitaxel CAS number 183133-96-2 is known to exist in a variety of crystalline forms that directly affect the drug's formulation processability and affect the stability, solubility and bioavailability of the drug, thereby affecting the quality, safety, availability of the drug and its application. His anhydrous crystalline form has a wide range of applications.

As can be seen from the existing patents, the main difficulty in the preparation of cabazitaxel lies in the first step C-7, C-10 methylation of paclitaxel extract 10-DAB, which can introduce a large amount of by-products, The temperature and reagent requirements are more stringent. The use of 7,10-bis-methoxy-10-DAB as a starting material for the preparation of cabazitaxel can shorten the reaction cycle, reduce the production difficulty of enterprises, which will benefit the realization of the latter part of industrialized production.

Thera. Category:  Anti-cancer

Cas No.: 183133-96-2

Synonym: Cabazitaxel;TXD-258; Cabazitaxel(XRP-6258)


Molecular Weight: 835.93238

Molecular formula: C45H57NO14

Assay: ≥98.%

Appearance: White Crystalline solid

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Active Pharmaceutical Ingredients> Cas 90098-04-7,Rebamipide Named In Mucosta With GMP Standard
Active Pharmaceutical Ingredients> Functional Dyspepsia Treatment Acotiamide Hydrochloride Trihydrate CAS 773092-05-0
Active Pharmaceutical Ingredients> Acotiamide Hydrochloride For Gastric Motility Improvement CAS 185104-11-4
Contract Manufacturing> ASCORBYL GLUCOSIDE Used for Comesitc Additive CAS 129499-78-1
Pharmaceutical Intermediates> Anti-Ulcerative> 2-Aminothiazole-4-ethylformate For Making Acotiamide Cas 5398-36-7
Pharmaceutical Intermediates> Anti-Ulcerative> Acotiamide INT CAS NUMBER 185105-98-0
Pharmaceutical Intermediates> Anti-Cardiovascular> Azilsartan Used for Hypertension Treatment CAS 147403-03-0
Pharmaceutical Intermediates> Anti-Diabetes> Sitagliptin Phosphate Monohydrate Treated for Type 2 diabetes CAS Number 654671-77-9
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 132210-24-3, 2-Amino-3-(1,2-dihydro-2-oxo-quinoline-4-yl)Propanoic acid Hydrochloride For Rebamipide
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 1068-90-2 White Crystalline Powder Diethyl Acetamidomalonate For Rebamipide(DAAM)
Active Pharmaceutical Ingredients> 6027-23-2, Hordenine HCL Powder
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 4876-10-2,4-Bromomethyl-2(1H)-quinolinone (BMQ) For Rebamipide/ Mucosta
Pharmaceutical Intermediates> Anti-Respiratory> CAS 2338-18-3, 2-Aminoindan hydrochloride For Making Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> CAS 312753-53-0/ 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Used for Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> 312753-53-0, Indacaterol Intermediate
Pharmaceutical Intermediates> Anti-Respiratory> 100331-89-3, Indacaterol Intermediate

© 2019 CHINA WAY. All Rights Reserved.  Taizhou Volsen Chemical Co., Ltd.,  Inc.   All rights reserved. site map.  sitemap.html